High dietary menaquinone intake is associated with reduced coronary calcification

作者: Joline W.J. Beulens , Michiel L. Bots , Femke Atsma , Marie-Louise E.L. Bartelink , Matthias Prokop

DOI: 10.1016/J.ATHEROSCLEROSIS.2008.07.010

关键词: Heart diseaseCalcificationRelative riskMedicineVascular diseaseInternal medicineArterial calcificationRelative validityMenopauseEndocrinologyMatrix gla protein

摘要: Abstract Background Dietary vitamin K is thought to decrease risk of cardiovascular disease by reducing coronary calcification, but inconsistent results are reported. This may be due different effects 1 (phylloquinone) and 2 (menaquinone, MK), few studies included both. Methods We investigated the association intake phylloquinone menaquinone, including its subtypes (MK4–MK10), with calcification in a cross-sectional study among 564 post-menopausal women. Phylloquinone menaquinone was estimated using food-frequency questionnaire. Results Sixty-two percent ( n =360) women had based on 1.5-mm thick slices. not associated relative (RR) 1.17 (95%-confidence interval: 0.96–1.42; p trend =0.11) highest versus lowest quartile. Menaquinone decreased an RR 0.80 (95%-CI: 0.65–0.98; =0.03). Conclusion shows that high dietary intake, probably phylloquinone, reduced calcification. Adequate intakes could therefore important prevent disease.

参考文章(36)
Suttie Jw, Vitamin K and human nutrition. Journal of The American Dietetic Association. ,vol. 92, pp. 585- 590 ,(1992)
A. Hoffer, Treatment of hyperkinetic children with nicotinamide and pyridoxine Canadian Medical Association Journal. ,vol. 107, pp. 111- 112 ,(1972)
Rosemary J. G. Price, Steven T. Fenton, Martin J. Shearer, Caroline Bolton-Smith, Dominic J. Harrington, Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. British Journal of Nutrition. ,vol. 83, pp. 389- 399 ,(2000) , 10.1017/S0007114500000490
Leon J. Schurgers, Hermann Aebert, Cees Vermeer, Burkhard Bültmann, Jan Janzen, Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood. ,vol. 104, pp. 3231- 3232 ,(2004) , 10.1182/BLOOD-2004-04-1277
Leon J. Schurgers, Cees Vermeer, Differential Lipoprotein Transport Pathways of K-vitamins in Healthy Subjects Biochimica et Biophysica Acta. ,vol. 1570, pp. 27- 32 ,(2002) , 10.1016/S0304-4165(02)00147-2
Sarah L. Booth, James A. Sadowski, John L. Weihrauch, Guylaine Ferland, Vitamin K1 (Phylloquinone) Content of Foods: A Provisional Table Journal of Food Composition and Analysis. ,vol. 6, pp. 109- 120 ,(1993) , 10.1006/JFCA.1993.1014
Ralf Koos, Andreas Horst Mahnken, Georg Mühlenbruch, Vincent Brandenburg, Benjamin Pflueger, Joachim Ernst Wildberger, Harald Peter Kühl, Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. American Journal of Cardiology. ,vol. 96, pp. 747- 749 ,(2005) , 10.1016/J.AMJCARD.2005.05.014
Sarah Cockayne, Joy Adamson, Susan Lanham-New, Martin J. Shearer, Simon Gilbody, David J. Torgerson, Vitamin K and the Prevention of Fractures: Systematic Review and Meta-analysis of Randomized Controlled Trials JAMA Internal Medicine. ,vol. 166, pp. 1256- 1261 ,(2006) , 10.1001/ARCHINTE.166.12.1256
Eiji Saito, Hiroshi Wachi, Fumiaki Sato, Hideki Sugitani, Yoshiyuki Seyama, Treatment with Vitamin K2 Combined with Bisphosphonates Synergistically Inhibits Calcification in Cultured Smooth Muscle Cells Journal of Atherosclerosis and Thrombosis. ,vol. 14, pp. 317- 324 ,(2007) , 10.5551/JAT.E501